Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Daniel O, Clegg"'
Autor:
Jessica A. Walsh, Shaobo Pei, Gopi K. Penmetsa, Jianwei Leng, Grant W. Cannon, Daniel O. Clegg, Brian C. Sauer
Publikováno v:
BMC Musculoskeletal Disorders, Vol 19, Iss 1, Pp 1-7 (2018)
Abstract Background Big data research is important for studying uncommon diseases in real-world settings. Most big data studies in axial spondyloarthritis (axSpA) have been limited to populations identified with billing codes for ankylosing spondylit
Externí odkaz:
https://doaj.org/article/44415f8ef4824a949d15557a33c7195c
Autor:
Kandi E. Velarde, Jennifer M. Romesser, Marcus R. Johnson, Daniel O. Clegg, Olga Efimova, Steven J. Oostema, Jeffrey S. Scehnet, Scott L. DuVall, Grant D. Huang
Publikováno v:
Contemporary Clinical Trials Communications, Vol 11, Iss , Pp 107-112 (2018)
Background: Randomized clinical trials are the gold standard for evaluating healthcare interventions and, more generally, add to the medical knowledge related to the treatment, diagnosis and prevention of diseases and conditions. Recent literature co
Externí odkaz:
https://doaj.org/article/ce2c9e91aed44bf8826b89815588ba3c
Autor:
Daniel O. Clegg, Elizabeth T. Chang, Prashant Kaushik, Elizabeth Cheng, Andreas M. Reimold, Jina Park, Delamo I. Bekele, Jessica A. Walsh, Maureen Dubreuil, Christian Geier, Kavya Ganuthula, Gail S. Kerr, Bernard Ng, Ryan Duong
Publikováno v:
Rheumatology International. 42:1925-1937
Although tumor necrosis factor inhibitors (TNFi) have favorably altered the treatment landscape for patients with axial spondyloarthritis (axSpA), there is limited data regarding TNFi persistence and reasons for discontinuation. This is an observatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9336b687d348f920b3574d1a7cb13218
https://doi.org/10.1007/s00296-021-05024-w
https://doi.org/10.1007/s00296-021-05024-w
Autor:
Allen D. Sawitzke, Christopher G. Jackson, Kimberly Carlson, Marcel D. Bizien, Mathew Leiner, Domenic J. Reda, Tom Sindowski, Christopher Hanrahan, Richard G. Spencer, C. Kent Kwoh, Susan J. Lee, Kalli Hose, Lisa Robin, Donna W. Cain, Meredith D. Taylor, Neal Bangerter, Martha Finco, Daniel O. Clegg
Publikováno v:
JAMA network open. 5(3)
Osteoarthritis (OA) is a major cause of disability in the US, with no approved treatments to slow progression, but animal models suggest that pulsed low-intensity ultrasonography (PLIUS) may promote cartilage growth.To evaluate the efficacy of PLIUS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3fdee3ac2dd60a7c1bdb80d664793b
https://pubmed.ncbi.nlm.nih.gov/35258579
https://pubmed.ncbi.nlm.nih.gov/35258579
Autor:
Delamo I, Bekele, Elizabeth, Cheng, Andreas, Reimold, Christian, Geier, Kavya, Ganuthula, Jessica A, Walsh, Daniel O, Clegg, Maureen, Dubreuil, Prashant, Kaushik, Bernard, Ng, Elizabeth, Chang, Ryan, Duong, Jina, Park, Gail S, Kerr
Publikováno v:
Rheumatology international. 42(11)
Although tumor necrosis factor inhibitors (TNFi) have favorably altered the treatment landscape for patients with axial spondyloarthritis (axSpA), there is limited data regarding TNFi persistence and reasons for discontinuation. This is an observatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2135e8006fc568519717595431010382
https://pubmed.ncbi.nlm.nih.gov/34724089
https://pubmed.ncbi.nlm.nih.gov/34724089
Autor:
Daniel O. Clegg, Jessica A. Walsh, Angela P. Presson, Chong Zhang, Brian Breviu, Tawnie J. Braaten
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 4:192-197
Introduction/Objectives: Gender is an important patient characteristic that may be used to predict clinical presentation, disease progression, and therapeutic response. In recent studies, women with psoriatic arthritis (PsA) have reported less favora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48fbd669978e28d7d94e437b9756152a
https://doi.org/10.1177/2475530319870776
https://doi.org/10.1177/2475530319870776
Autor:
Jessica A. Walsh, Shaobo Pei, Grant W. Cannon, Daniel O. Clegg, Gopi K. Penmetsa, Brian C. Sauer, Jared L. Hansen
Publikováno v:
The Journal of Rheumatology. 47:42-49
Objective.Observational axial spondyloarthritis (axSpA) research in large datasets has been limited by a lack of adequate methods for identifying patients with axSpA, because there are no billing codes in the United States for most subtypes of axSpA.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eeba6b446e5ff7d98447e2701640633
https://doi.org/10.3899/jrheum.181005
https://doi.org/10.3899/jrheum.181005
Autor:
Gopi K. Penmetsa, Daniel O. Clegg, Shaobo Pei, Brian C. Sauer, Jessica A. Walsh, Rebecca S. Overbury
Publikováno v:
The Journal of rheumatology. 48(5)
ObjectiveObservational research of axial spondyloarthritis (axSpA) is limited by a lack of methods for identifying diverse axSpA phenotypes in large datasets. Algorithms were previously designed to identify a broad spectrum of patients with axSpA, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93526f1c79a8fb394fb047e4616c2652
https://pubmed.ncbi.nlm.nih.gov/33259327
https://pubmed.ncbi.nlm.nih.gov/33259327
Autor:
Annette Szumski, Kristina Callis Duffin, Heather Jones, Daniel O. Clegg, Jessica A. Walsh, Lotus Mallbris, Gerald G. Krueger
Publikováno v:
Psoriasis: Targets and Therapy
Jessica A Walsh,1 Heather Jones,2 Lotus Mallbris,2 Kristina Callis Duffin,3 Gerald G Krueger,3 Daniel O Clegg,1 Annette Szumski4 1Division of Rheumatology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, US
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3702452fa27ce8a7fa1f477357b08a96
https://doi.org/10.2147/ptt.s169333
https://doi.org/10.2147/ptt.s169333
Autor:
Steven J. Oostema, Marcus R. Johnson, Jennifer M. Romesser, Scott L. DuVall, Grant D. Huang, Olga Efimova, Jeffrey S. Scehnet, Daniel O. Clegg, Kandi E. Velarde
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 11, Iss, Pp 107-112 (2018)
Contemporary Clinical Trials Communications, Vol 11, Iss, Pp 107-112 (2018)
Background: Randomized clinical trials are the gold standard for evaluating healthcare interventions and, more generally, add to the medical knowledge related to the treatment, diagnosis and prevention of diseases and conditions. Recent literature co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deefc6c9c9cb51ddb3cba7a7785dfd6d
http://europepmc.org/articles/PMC6052195
http://europepmc.org/articles/PMC6052195